Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX)
CUSIP: 28036F105
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 109,183,673
- Total 13F shares
- 105,289,941
- Share change
- +6,545,955
- Total reported value
- $2,320,227,206
- Put/Call ratio
- 57%
- Price per share
- $22.00
- Number of holders
- 190
- Value change
- +$130,326,516
- Number of buys
- 98
- Number of sells
- 100
Quarterly Holders Quick Answers
What is CUSIP 28036F105?
CUSIP 28036F105 identifies EWTX - Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28036F105:
Top shareholders of EWTX - Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
14%
|
15,021,721
|
$401,079,951 | — | 31 Dec 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
8.2%
|
8,909,091
|
$237,872,730 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.9%
|
6,479,015
|
$172,989,701 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.6%
|
6,155,940
|
$164,363,598 | — | 31 Dec 2024 | |
| Novo Holdings A/S |
13F
3/4/5
|
Company · 10%+ Owner |
4.6%
|
5,000,000
|
$133,500,000 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.6%
|
4,983,940
|
$133,043,956 | — | 31 Dec 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
4.1%
|
4,493,929
|
$119,987,904 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
4,466,849
|
$119,264,868 | — | 31 Dec 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.1%
|
3,406,534
|
$90,954,458 | — | 31 Dec 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.5%
|
2,685,537
|
$71,703,838 | — | 31 Dec 2024 | |
| BRAIDWELL LP |
13F
|
Company |
2.1%
|
2,332,196
|
$62,269,633 | — | 31 Dec 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.9%
|
2,078,509
|
$55,496,190 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
1,715,545
|
$45,805,052 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,600,571
|
$42,743,958 | — | 31 Dec 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,493,791
|
$39,884,220 | — | 31 Dec 2024 | |
| Bellevue Group AG |
13F
|
Company |
1.3%
|
1,428,929
|
$38,152,404 | — | 31 Dec 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.2%
|
1,271,245
|
$33,942,242 | — | 31 Dec 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
1.1%
|
1,224,986
|
$32,707,126 | — | 31 Dec 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.99%
|
1,079,316
|
$28,817,737 | — | 31 Dec 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.98%
|
1,071,596
|
$28,611,613 | — | 31 Dec 2024 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
0.94%
|
1,030,161
|
$27,505,299 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.81%
|
888,968
|
$23,735,446 | — | 31 Dec 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.71%
|
780,639
|
$20,843,061 | — | 31 Dec 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.71%
|
770,353
|
$20,568,455 | — | 31 Dec 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
0.67%
|
734,343
|
$19,606,958 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.67%
|
729,923
|
$19,490,835 | — | 31 Dec 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
0.65%
|
710,421
|
$18,968,241 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.63%
|
686,371
|
$18,326,106 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
611,306
|
$16,321,870 | — | 31 Dec 2024 | |
| Foresite Capital Management VI LLC |
13F
|
Company |
0.54%
|
585,000
|
$15,619,500 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.52%
|
567,218
|
$15,144,721 | — | 31 Dec 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.5%
|
550,000
|
$14,685,000 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
537,359
|
$14,347,485 | — | 31 Dec 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.44%
|
480,000
|
$12,816,000 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.43%
|
469,451
|
$12,534,342 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.4%
|
436,430
|
$11,652,693 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.39%
|
428,858
|
$11,450,508 | — | 31 Dec 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.37%
|
402,773
|
$10,754,039 | — | 31 Dec 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.37%
|
400,000
|
$10,680,000 | — | 31 Dec 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.35%
|
381,173
|
$10,177,319 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.34%
|
369,442
|
$9,864,101 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.32%
|
346,891
|
$9,261,989 | — | 31 Dec 2024 | |
| Amundi |
13F
|
Individual |
0.31%
|
341,687
|
$8,685,684 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.28%
|
301,241
|
$8,043,135 | — | 31 Dec 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.27%
|
300,013
|
$8,010,347 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
300,000
|
$8,010,000 | — | 31 Dec 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.26%
|
284,148
|
$7,586,752 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.26%
|
279,125
|
$7,452,637 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.25%
|
275,837
|
$7,364,848 | — | 31 Dec 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.25%
|
268,509
|
$7,169,190 | — | 31 Dec 2024 |
Institutional Holders of Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) as of Q1 2025
As of 31 Mar 2025,
Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) was held by
190 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
105,289,941 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, BlackRock, Inc., BAKER BROS. ADVISORS LP, Novo Holdings A/S, JANUS HENDERSON GROUP PLC, Paradigm Biocapital Advisors LP, VANGUARD GROUP INC, and Cormorant Asset Management, LP.
This page lists
190
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
197
Q1 2025 holders
190
Holder diff
-7
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.